More than 25 million rubles to be allocated to “Elapraza” drug purchase in Penza region
Print
Penza, 30 October 2013. PenzaNews. The public auction in the electronic form on the supply of the medical product “Elapraza,” used for long-term treatment of patients with Hunter syndrome, was announced by the Ministry of Health of the Penza region on the official portal of the government procurement on Wednesday, October 30.
The initial (maximum) contract price is 25 million 798 thousand 500 rubles.
According to the posted information, the payee is the Regional Children’s Clinical Hospital named after N.F. Filatov.
The public auction in the electronic form will take place on November 25.
It is expected that the drug will be delivered to the Children’s hospital within 10 workdays from the date of the state contract conclusion.
As news agency PenzaNews reported earlier, in August 2013 the court at the request of the prosecutor ordered the Ministry of Health of the Penza region to provide free treatment to the boy, born in 1998 with Hunter syndrome, who needs ferment-substitutive therapy with the drug “Elapraze.”